Concurrent Investment Advisors LLC Decreases Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Concurrent Investment Advisors LLC trimmed its position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 3.0% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 21,333 shares of the healthcare conglomerate's stock after selling 666 shares during the quarter. Concurrent Investment Advisors LLC's holdings in UnitedHealth Group were worth $10,791,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. AlphaMark Advisors LLC acquired a new stake in UnitedHealth Group during the fourth quarter worth about $30,000. RPg Family Wealth Advisory LLC purchased a new stake in shares of UnitedHealth Group during the 3rd quarter valued at approximately $37,000. DecisionPoint Financial LLC increased its stake in UnitedHealth Group by 155.0% during the fourth quarter. DecisionPoint Financial LLC now owns 102 shares of the healthcare conglomerate's stock worth $52,000 after acquiring an additional 62 shares during the last quarter. Highline Wealth Partners LLC purchased a new position in shares of UnitedHealth Group during the 3rd quarter worth $55,000. Finally, Legacy Investment Solutions LLC acquired a new position in UnitedHealth Group in the third quarter valued at about $57,000. Hedge funds and other institutional investors own 87.86% of the company's stock.

Analyst Upgrades and Downgrades

UNH has been the topic of several recent analyst reports. Stephens upped their price objective on shares of UnitedHealth Group from $605.00 to $675.00 and gave the stock an "overweight" rating in a report on Thursday, December 5th. Wells Fargo & Company lowered their price target on UnitedHealth Group from $694.00 to $660.00 and set an "overweight" rating for the company in a research report on Tuesday, January 28th. Hsbc Global Res raised UnitedHealth Group from a "hold" rating to a "strong-buy" rating in a research note on Friday, January 10th. KeyCorp reiterated an "overweight" rating and set a $650.00 price target on shares of UnitedHealth Group in a research note on Friday, January 17th. Finally, Piper Sandler dropped their price objective on shares of UnitedHealth Group from $605.00 to $600.00 and set an "overweight" rating for the company in a report on Thursday, January 2nd. One research analyst has rated the stock with a hold rating, twenty have given a buy rating and two have given a strong buy rating to the company's stock. According to data from MarketBeat, UnitedHealth Group currently has an average rating of "Buy" and a consensus target price of $629.32.

Insider Buying and Selling at UnitedHealth Group

In related news, Director Timothy Patrick Flynn bought 1,000 shares of the company's stock in a transaction dated Friday, January 17th. The shares were acquired at an average price of $511.57 per share, with a total value of $511,570.00. Following the completion of the acquisition, the director now owns 4,500 shares in the company, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.33% of the stock is currently owned by company insiders.

UnitedHealth Group Stock Down 7.3 %

Shares of UnitedHealth Group stock traded down $36.84 during trading hours on Friday, hitting $465.58. The company had a trading volume of 18,300,797 shares, compared to its average volume of 4,729,468. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $630.73. The company has a market cap of $428.46 billion, a P/E ratio of 30.04, a price-to-earnings-growth ratio of 1.40 and a beta of 0.61. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. The company's 50-day moving average is $520.37 and its two-hundred day moving average is $561.26.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating the consensus estimate of $6.74 by $0.07. The business had revenue of $100.81 billion during the quarter, compared to the consensus estimate of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business's quarterly revenue was up 6.8% on a year-over-year basis. During the same period in the previous year, the business earned $5.83 EPS. Analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.